Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Which Rules Apply Now for Adult Acne Patients

Adult acne patients who can become pregnant must still complete pretreatment pregnancy testing in a medical setting under iPLEDGE in 2026. iPLEDGE is the required safety program for isotretinoin, a prescription drug for severe nodular acne. The 2026 rules keep the two-test pretreatment sequence in place. Drugs.com reporting FDA action says the FDA approval notice approved changes on Feb.

9, 2026 to lower burden while keeping safe use. Lachman Consultants reporting FDA announcement notes the implementation update moved the start to Nov. 15, 2026 for testing and access. Ask your prescriber which workflow your clinic follows now.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Official resources:

Read the official guidance from FDA — Use this primary source to verify the official guidance.
Explore the official data from FDA — Use this primary source to review the underlying data.

What do the two pretreatment tests require?
Where must pretreatment testing happen?
Which pregnancy prevention rule pairs with testing?
What if you miss a prescription window?
When do the 2026 changes actually apply?

What do the two pretreatment tests require?

The FDA advisory committee briefing document describes the pretreatment testing sequence as two negative tests around one month of pregnancy prevention. The first test establishes baseline status before the prevention period. The second test confirms you are not pregnant before therapy starts.

That second confirmatory test must occur during the first 5 days of your menstrual cycle. The 30-day interval between tests must include either two contraceptive methods or abstinence. Plan appointment timing around your cycle, not around prescription pickup.

Get test one in a medical setting
Use prevention for 30 days
Get test two in the first 5 days of your period
Start isotretinoin only after the second negative result

Where must pretreatment testing happen?

The National Community Pharmacists Association reports pretreatment tests must occur in a medical setting such as a prescriber office or laboratory. That rule applies to adult acne patients who can become pregnant. A clinic urine or blood test counts when staff collect and document it.

Dermatology Advisor reporting FDA REMS changes distinguishes later testing from pretreatment testing. Home pregnancy tests are allowed only during and after treatment, not before treatment starts. If your prescriber uses home tests later, the practice must have steps to reduce false-negative or falsified results.

Which pregnancy prevention rule pairs with testing?

The FDA iPLEDGE Contraception Counseling Guide pairs testing with one month of prevention before, during, and after treatment. Patients who can become pregnant must use two approved birth-control forms together. Continuous abstinence is the other accepted option.

Two methods means using them at the same time, not switching between them. Examples include a hormonal method plus a barrier method when both are iPLEDGE-approved for you. Tell your prescriber about missed pills, vomiting, diarrhea, or missed injections right away.

Use two approved forms together for 1 month before isotretinoin
Continue both forms during treatment
Continue both forms for 1 month after the last dose
Choose continuous abstinence instead only if you will maintain it fully

What if you miss a prescription window?

The Journal of Dermatology for NPs/PAs reports FDA removed the 19-day lockout after a missed 7-day prescription window. You no longer face that added waiting period. Your prescriber can order an immediate repeat pregnancy test.

That change reduces delays for adults juggling work, school, or pharmacy hours. A missed pickup still requires a new negative test before dispensing. Keep your iPLEDGE questions, pregnancy-test timing, and pharmacy visit in the same week when possible.

When do the 2026 changes actually apply?

FDA first set implementation for August 2026, 180 days after the February approval. The later schedule moved full implementation to Nov. 15, 2026 for system testing and uninterrupted access.

Clinics may therefore use the current process until the updated system is live. That timing matters because pretreatment testing stays strict under either version. Do not assume home testing or fewer visits apply before your clinic switches. Bring your menstrual calendar, contraception record, and test results to each pretreatment visit.